August 15, 2017

Amicus Therapeutics Announces Approval for Galafold™ (Migalastat) for Treatment of Fabry Disease in Australia

August 7, 2017

Amicus Therapeutics Announces Second Quarter 2017 Financial Results and Corporate Updates

July 25, 2017

Amicus Therapeutics to Announce Second Quarter 2017 Financial Results on August 7, 2017